Skip to main content
The George Institute for Global Health
  • About us

    About us

    We are on a mission to improve global health. Through rigorous, high-quality research, we’re striving to achieve meaningful and lasting change on a local and global scale. 
    Discover who we are
    • Governance
      • Board of directors
      • Executive leadership team
      • Policies
      • Annual reports and financial statements
    • Our people
      • People at The George Institute
      • Emerging thought leaders
      • Distinguished fellows
    • Affiliates and partners
    • Centre for Research, Evidence and Skills Training
    • Innovation
    • Careers
    Medical research careers
    We are hiring!

    Careers

    At The George Institute, your work will help find solutions to some of the world’s greatest health challenges.  We are not just a workplace - we are a community united by a shared mission.
    Work with us
  • Our research

    Our research

    Our research finds solutions to some of the world’s biggest health challenges in critical areas including women’s health, planetary health, and food policy. Within each program, individual projects target specific challenges, providing local solutions to improve global outcomes.   
    Learn more about our research
    • Areas of our research
    • Our research projects
    • Clinical and community trials

    Our Research Mega Menu Cards Container

  • Our impact

    Our impact

    Our high quality, rigorous research makes a real difference to people's health, particularly those facing the most barriers.
    Find out more about the impact of our work
    • Stories of our impact
    • Policy statements and recommendations
    • Impact Report

    Impact Mega Menu Cards Container

  • News & media

    News and media

    Stay up to date with the latest breakthroughs, stories, and developments in global health research from The George Institute. Access articles, videos, and updates that spotlight our work across the world.
    Explore the latest news and insights
    • News
    • Events
    • Videos
    • Podcasts

    News and Media Mega Menu Cards Container

  • Support us

    Support us

    Help us make a lasting impact. By supporting our independent research, you fuel life-saving innovations that improve health outcomes for millions around the globe.
    See how you can support global health innovation
    • Donate
    • Ways to give
    • Your impact
    • Get involved

    Support us Mega Menu Cards Container

    Face of a woman looking ahead

    Be a part of our mission for healthier and longer lives

    Our research relies on the generous support of people like you. Show your support for breakthrough medical research today.
    Donate now
Donate

Filters

Filter by date

The Meniscal Transplant surgery or Optimised Rehabilitation full randomised trial (MeTeOR2)

BackgroundThe meniscus is a c-shaped knee cartilage structure which distributes force between joint surfaces. Meniscal tears can occur, and often the torn parts are removed with keyhole surgery called arthroscopic partial meniscectomy. In Australia approximately 37,000 meniscectomies were performed between 2020-21, 10% were in young adults (< 30 years). Some people have considerable and persistent pain and impaired function after meniscectomy, and how to best treat this is unknown. Meniscal Allograft Transplant (MAT) is a treatment option where a donor meniscus is implanted into the knee. However, there is a lack of evidence whether this procedure is superior to physiotherapy.AimTo see if MAT surgery or Personalised Knee Therapy (PKT) is the most clinically and or cost-effective treatment, for people with knee pain and/or functional loss after a meniscectomy.Research MethodologyMETEOR2 is a two-armed multi-centred pragmatic, international, randomised controlled trial to assess the cost-effectiven

Submission: Draft National Health and Medical Research Strategy consultation

Policy & Practice Report

Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)

Current status– finished recruitment – in follow-up.TRIDENT is an international medical research study which aims to determine the effect of more intensive blood pressure control to prevent recurrent stroke in patients who have had an intracerebral haemorrhage (ICH) (a stroke caused by ruptured blood vessel in the brain). The aim of this project is to test the superiority of a fixed low-dose combination blood pressure-lowering pill (Triple Pill) strategy in recurrent stroke in patients with a history of ICH.Acute ICH accounts for at least 10% of the 20 million new strokes in the world each year. ICH survivors are at high risk of recurrent stroke and other serious cardiovascular events. Numerous studies have proven the benefit of stroke survivors reducing their risk of recurrent stroke through taking blood pressure-lowering medications. However, studies have shown that many ICH survivors are either not receiving any blood pressure-lowering medication or they are receiving inadequate control.The TRIDENT stu

The TReAT trial: Mobile application for rehabilitation support after knee replacement

Background Knee replacement improves the quality of life for those suffering from disabling knee osteoarthritis. Physiotherapy is an important component of the rehabilitation phase following surgery for restoring function and improving quality of life. However, poor adherence to physical therapy due to various socio-environmental and patient-related factors delays recovery. A lack of mechanism for the continuum of care following discharge to home leads to sub-optimal outcomes, chronic knee pain and patient dissatisfaction in some proportions of individuals. Evidence suggests that home-based physical rehabilitation with a monitoring mechanism is as good as and cost-effective compared to clinic-based rehabilitation. In India, unsupervised home-based rehabilitation is the usual care, leading to a considerable amount of out-of-pocket expenditure to seek physiotherapist support at home. Hence, keeping the local requirements and literacy level in mind, a customised and context-specific rehabilitation monitori

REVERSE: Reducing cardiovascular and kidney risk in diabetes

Background Diabetes is a major public health challenge, causing additional complications across multiple organ systems. Cardiovascular disease (CVD) and chronic kidney disease (CKD) are the leading causes of disability and death in people with type 2 diabetes mellitus (T2DM). In Australia, T2DM prevalence has nearly tripled in recent decades, with around 1.3 million people affected. The condition carries enormous economic and societal costs. T2DM has a major impact in socioeconomically disadvantaged areas like Western Sydney, South-Western Sydney, and regional NSW, where high prevalence and CVD/CKD complications represent major challenges for local health services. Treatments to slow and prevent the CVD/CKD effects of diabetes exist, but they rely on a health system that can readily identify high-risk patients, implement, and monitor treatment, and coordinate the complex care of such patients. Although proven strategies to delay and prevent the impacts of CVD and CKD in high-risk diabet

Assessment of absolute cardiovascular disease risk

Policy & Practice Report

Evidence library

Please find below a list of the key publications supporting the case for potassium-enriched salt. For a more comprehensive list, click here or to return to the main page click here.  Trials Effect of Salt Substitution on Cardiovascular Events and Death.New England Journal of Medicine, 2021https://www.nejm.org/doi/full/10.1056/nejmoa2105675 Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial.Nature Medicine, 2023https://www.nature.com/articles/s41591-023-02286-8 Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis.Heart 2022https://heart.bmj.com/content/108/20/1608.long  Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trialThe American Journal of Clinical Nutrition, 2021https://www.sciencedirect.com/science/article/pii/S0002916522003185

A guide to potassium-enriched salt

Please find below downloadable one-page guides for consumers and health professionals with key information on potassium-enriched salt. For health professionalsA guide to potassium-enriched salt.Learn more For consumersA guide to potassium-enriched salt.Learn more WHO guidelineA summary for policy makersLearn more FactsheetSwitching the world’s salt supply: Scaling up the use of potassium-enriched salt.Learn more For meal producersLearn more EvidenceUK evidence on using low-sodium salt substitutes.Learn more

Why do we need to #SwitchTheSalt?

Why do we need to #SwitchTheSalt? Almost everyone eats salt and almost everyone eats too much of it. Eating too much salt increases blood pressure, leading to heart attacks, strokes and deaths. Despite the efforts by governments and medical organisations over the last decade to reduce population salt intakes, little progress has been made. This is because people have become accustomed to the taste and dietary habits are hard to change. Salt is also a widely used ingredient in food manufacturing, and progress towards lowering levels in packaged foods has been slow. Find out more about our work to scale up the use of potassium-enriched salt across the global food supply. What is potassium-enriched salt? Potassium-enriched salt is a practical and scalable approach to lowering blood pressure and with it, the risk of strokes, heart attacks and death. Salt is made up of 100% sodium and chloride. A potassium-enriched salt, however, has some of the harmful sodium chloride replaced wi

How can we use the Global Burden of Disease study to achieve Sustainable Development Goal 3.2?

Video 06 Feb 2020

Dr Juan Rivera discusses the challenges and benefits of the sugar tax in Mexico

Video 24 Jul 2019

Carolyn A. Reynolds discusses the importance of global health security

Video 14 Jul 2019

Pagination

  • Previous page
  • Page 140
  • Page 141
  • Page 142
  • Page 143
  • Page 144
  • Next page
globe illustration on desktop globe illustration on mobile
The George Institute for Global Health

    Quick links

    • About us
    • Our research
    • Our impact
    • News & media
    • Contact us

    Acknowledgement of country

    The George Institute acknowledges First Peoples and the Traditional Custodians of the many lands upon which we live and work. We pay our respects to Elders past and present, and thank them for ongoing custodianship of waters, lands and skies.

    Our Partners

    The George Institute for Global Health is proud to work in partnership with UNSW Sydney, Imperial College London and the Manipal Academy of Higher Education, India.

    Registered charity logo
    The George Institute for Global Health is a registered charity. ABN 90 085 953 331

    Stay connected

    Enter your details to subscribe to our newsletter.




    By submitting this form, you are agreeing to our Privacy Policy.


    reCAPTCHA helps prevent automated form spam.
    The submit button will be disabled until you complete the CAPTCHA.


    Disclaimer and policy menu

    • Disclaimer
    • Privacy policy
    • Data sharing policy
    • Whistleblower policy
    • Modern slavery statement
    • Working with children and adolescents' policy
    • Research code of conduct policy
    • PHS awards financial COI policy
    • Sitemap
    Affiliated with UNSW Sydney. In partnership with Imperial College London and Manipal Academy of Higher Education, India.

    Copyright © 2026 The George Institute for Global Health.

    Website by Marameo Design

    Cookie Policy | Privacy Policy